Suppr超能文献

皮肤 CD4+/CD56+ 血外生性肿瘤。

Cutaneous CD4+/CD56+ hematodermic neoplasm.

机构信息

Department of Dermatology, Goztepe Training and Resach Hospital, Istanbul, Turkey.

出版信息

Indian J Dermatol Venereol Leprol. 2010 Nov-Dec;76(6):723. doi: 10.4103/0378-6323.72471.

Abstract

CD4+/CD56+ hematodermic neoplasm, formerly known as blastic NK cell lymphoma, is a rare and aggressive neoplasm with a high incidence of cutaneous involvement, risk of leukemic dissemination and poor prognosis. The characteristic features are expression of the T helper inducer cell marker CD4 and the NK-cell marker CD56 in the absence of other T cell or NKcell specific markers. Because of the rarity of this disease, we describe a 48 year old woman suffering from CD4+/CD56+ hematodermic neoplasm on her cheek without leukemic infiltration.

摘要

CD4+/CD56+ 血液皮肤肿瘤,以前称为成髓细胞 NK 细胞淋巴瘤,是一种罕见且侵袭性的肿瘤,皮肤受累风险高,有白血病播散的风险,且预后不良。其特征在于表达 T 辅助诱导细胞标志物 CD4 和 NK 细胞标志物 CD56,但缺乏其他 T 细胞或 NK 细胞特异性标志物。由于这种疾病较为罕见,我们描述了一例 48 岁女性,其脸颊患有 CD4+/CD56+ 血液皮肤肿瘤,但无白血病浸润。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验